ClariVest Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$1.7M	Hold	32,012	–	–	0.17%	167
2024 Q2	$1.7M	Buy	32,012 +22,642	+242%	+$1.2M	0.17%	167
2024 Q1	$768K	Buy	+9,370	New	+$768K	0.08%	310